InsiderSignal.AI

InsiderSignal.ai

ABT - Abbott Laboratories

Insider Purchase by Starks Daniel J (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 weeks ago, Starks Daniel J, serving as Dir at Abbott Laboratories (ABT), purchased 10,000 shares at $108.73 per share, for a total transaction value of $1,087,331.00. Following this transaction, Starks Daniel J now holds 6,739,075 shares of ABT.

The trade was executed on Wednesday, February 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 6, 2026, 2 days after the trade was made.

Abbott Laboratories operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Starks Daniel J

Dir

Daniel J. Starks is a seasoned healthcare executive serving as an Independent Director on the Board of Directors of Abbott Laboratories (ABT) since February 15, 2017.[[1]](https://www.abbott.com/en-us/about-abbott/leadership/board-of-directors/daniel-j-starks)[[2]](https://www.marketscreener.com/insider/DANIEL-STARKS-A000UQ/)[[5]](https://www.abbott.com/en-us/about-abbott/leadership) He recently engaged in insider trading activities at Abbott Laboratories as a Director.[[3]](https://www.gurufocus.com/insider/6254/daniel-j-starks)[[7]](https://www.benzinga.com/sec/insider-trades/0000902132/daniel-j-starks) Starks had a distinguished career at St. Jude Medical, Inc., joining in 1996 and rising to Chairman, President, and Chief Executive Officer from 2004 until his retirement in January 2016, followed by serving as Executive Chairman until Abbott's acquisition of the company in January 2017.[[1]](https://www.abbott.com/en-us/about-abbott/leadership/board-of-directors/daniel-j-starks)[[6]](https://www.sec.gov/Archives/edgar/data/1800/000104746921000455/a2242893zpre14a.htm) Earlier roles included President and Chief Operating Officer (2001-2004) and President and CEO of the Cardiac Rhythm Management Business (1997-2001).[[1]](https://www.abbott.com/en-us/about-abbott/leadership/board-of-directors/daniel-j-starks) He previously led companies such as Daig Corp. (acquired by St. Jude in 1996), Advanced Neuromodulation Systems, Inc., Epicor Medical, Inc., and Cardiac Rhythm Management as President and CEO.[[2]](https://www.marketscreener.com/insider/DANIEL-STARKS-A000UQ/) Starks brings extensive expertise in the medical device industry and global public company management to Abbott's board.[[1]](https://www.abbott.com/en-us/about-abbott/leadership/board-of-directors/daniel-j-starks) His ownership includes over 6.7 million ABT shares, contributing to an estimated net worth exceeding $700 million.[[3]](https://www.gurufocus.com/insider/6254/daniel-j-starks)[[4]](https://dan-starks-net-worth.pages.dev/posts/dan-starks-net-worth/)

View full insider profile →

Trade Price

$108.73

Quantity

10,000

Total Value

$1,087,331.00

Shares Owned

6,739,075

Trade Date

Wednesday, February 4, 2026

18 days ago

SEC Filing Date

Friday, February 6, 2026

Filed 2 days after trade

HEALTHCAREMEDICAL DEVICES

About Abbott Laboratories

Company Overview

No company information available
View news mentioning ABT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3746451

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime